{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:20:14Z","timestamp":1791040814296,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00774-008-0871-3","type":"journal-article","created":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T10:41:20Z","timestamp":1225449680000},"page":"624-634","source":"Crossref","is-referenced-by-count":37,"title":["Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study"],"prefix":"10.1007","volume":"26","author":[{"given":"Akimitsu","family":"Miyauchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Shigeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Thiebaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,1]]},"reference":[{"issue":"29","key":"871_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6290","volume":"6","author":"J.A. Kanis","year":"2002","unstructured":"Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd Jones M (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 6(29): 1\u2013146","journal-title":"Health Technol Assess"},{"issue":"19","key":"871_CR2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"R.M. Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19): 1434\u20131441","journal-title":"N Engl J Med"},{"issue":"15","key":"871_CR3","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","volume":"165","author":"M.R. McClung","year":"2005","unstructured":"McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, Donley DW, Dalsky GP, Eriksen EF (2005) Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 165(15):1762\u20131768","journal-title":"Arch Intern Med"},{"issue":"1","key":"871_CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1359\/jbmr.061011","volume":"22","author":"T.M. Keaveny","year":"2007","unstructured":"Keaveny TM, Donley DW, Hoffmann PF, Mitlak BH, Glass EV, San Martin JA (2007) Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res 22(1): 149\u2013157","journal-title":"J Bone Miner Res"},{"issue":"11","key":"871_CR5","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","volume":"18","author":"Y. Jiang","year":"2003","unstructured":"Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1\u201334) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18(11):1932\u20131941","journal-title":"J Bone Miner Res"},{"issue":"1","key":"871_CR6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jbspin.2006.06.004","volume":"74","author":"C.L. Benhamou","year":"2007","unstructured":"Benhamou CL (2007) Effects of osteoporosis medications on bone quality. Joint Bone Spine 74(1):39\u201347","journal-title":"Joint Bone Spine"},{"key":"871_CR7","first-page":"10","volume-title":"Handbook for Bone\/Calcium Test (in Japanese)","author":"T. Miki","year":"1996","unstructured":"Miki T, Naka H (1996) Tests for calcium metabolism. In: Morii H (ed) Handbook for Bone\/Calcium Test (in Japanese). Nakayama-Shoten, Tokyo, pp 10\u201314"},{"issue":"6","key":"871_CR8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","volume":"16","author":"J.A. Kanis","year":"2005","unstructured":"Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16(6):581\u2013589","journal-title":"Osteoporos Int"},{"issue":"8","key":"871_CR9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"J.A. Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, et al. (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033\u20131046","journal-title":"Osteoporos Int"},{"issue":"1","key":"871_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00024677-200605010-00003","volume":"5","author":"J.Y. Reginster","year":"2006","unstructured":"Reginster JY, Sarlet N (2006) The treatment of severe postmenopausal osteoporosis: a review of current and emerging therapeutic options. Treat Endocrinol 5(1):15\u201323","journal-title":"Treat Endocrinol"},{"issue":"5","key":"871_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00774-007-0760-1","volume":"25","author":"H. Hagino","year":"2007","unstructured":"Hagino H (2007) Features of limb fractures: a review of epidemiology from a Japanese perspective. J Bone Miner Metab 25(5): 261\u2013265","journal-title":"J Bone Miner Metab"},{"issue":"10","key":"871_CR12","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1359\/jbmr.1999.14.10.1691","volume":"14","author":"A. Sakai","year":"1999","unstructured":"Sakai A, Sakata T, Ikeda S, Uchida S, Okazaki R, Norimura T, Hori M, Nakamura T (1999) Intermittent administration of human parathyroid hormone (1\u201334) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice. J Bone Miner Res 14(10):1691\u20131699","journal-title":"J Bone Miner Res"},{"issue":"50","key":"871_CR13","doi-asserted-by":"crossref","first-page":"50259","DOI":"10.1074\/jbc.M307444200","volume":"278","author":"T. Bellido","year":"2003","unstructured":"Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O\u2019Brien CA, Manolagas SC, Jilka RL (2003) Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278(50):50259\u201350272","journal-title":"J Biol Chem"},{"issue":"3","key":"871_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/8756-3282(93)90190-L","volume":"14","author":"A.B. Hodsman","year":"1993","unstructured":"Hodsman AB, Steer BM (1993) Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces. Bone (NY) 14(3):523\u2013527","journal-title":"Bone (NY)"},{"issue":"6","key":"871_CR15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1359\/jbmr.060314","volume":"21","author":"Y.L. Ma","year":"2006","unstructured":"Ma YL, Zeng Q, Donley DW, Ste-Marie LG, Gallagher JC, Dalsky GP, Marcus R, Eriksen EF (2006) Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGFII immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res 21(6):855\u2013864","journal-title":"J Bone Miner Res"},{"issue":"3","key":"871_CR16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","volume":"21","author":"R. Lindsay","year":"2006","unstructured":"Lindsay R, Cosman F, Zhou H, Bostrom MP, Shen VW, Cruz JD, Nieves JW, Dempster DW (2006) A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide. J Bone Miner Res 21(3):366\u2013373","journal-title":"J Bone Miner Res"},{"issue":"6","key":"871_CR17","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.bone.2006.09.008","volume":"40","author":"J.E. Compston","year":"2007","unstructured":"Compston JE (2007) Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure. Bone (NY) 40(6):1447\u20131452","journal-title":"Bone (NY)"},{"issue":"4","key":"871_CR18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s001980050151","volume":"9","author":"T. Fujita","year":"1999","unstructured":"Fujita T, Inoue T, Morii H, Morita R, Norimatsu H, Orimo H, Takahashi HE, Yamamoto K, Fukunaga M (1999) Effect of an intermittent weekly dose of human parathyroid hormone (1\u201334) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporos Int 9(4):296\u2013306","journal-title":"Osteoporos Int"},{"issue":"10","key":"871_CR19","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00198-006-0159-1","volume":"17","author":"T. Matsumoto","year":"2006","unstructured":"Matsumoto T, Shiraki M, Hagino H, Iinuma H, Nakamura T (2006) Daily nasal spray of hPTH (1\u201334) for 3 months increases bone mass in osteoporotic subjects: a pilot study. Osteoporos Int 17(10):1532\u20131538","journal-title":"Osteoporos Int"},{"issue":"11","key":"871_CR20","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1359\/jbmr.060802","volume":"21","author":"P. Chen","year":"2006","unstructured":"Chen P, Miller PD, Delmas PD, Misurski DA, Krege JH (2006) Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis. J Bone Miner Res 21(11):1785\u20131790","journal-title":"J Bone Miner Res"},{"issue":"8","key":"871_CR21","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1359\/jbmr.070413","volume":"22","author":"P. Chen","year":"2007","unstructured":"Chen P, Miller PD, Recker R, Resch H, Rana A, Pavo I, Sipos AA (2007) Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis. J Bone Miner Res 22(8):1173\u20131180","journal-title":"J Bone Miner Res"},{"issue":"1","key":"871_CR22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1359\/jbmr.2003.18.1.18","volume":"18","author":"R. Marcus","year":"2003","unstructured":"Marcus R, Wang O, Satterwhite J, Mitlak B (2003) The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res 18(1):18\u201323","journal-title":"J Bone Miner Res"},{"issue":"5","key":"871_CR23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1185\/030079906X104768","volume":"22","author":"A.W. Kung","year":"2006","unstructured":"Kung AW, Pasion EG, Sofiyan M, Lau EM, Tay BK, Lam KS, Wilawan K, Ongphiphadhanakul B, Thiebaud D (2006) A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6-month study. Curr Med Res Opin 22(5):929\u2013937","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"871_CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00198-005-2002-5","volume":"17","author":"J.S. Hwang","year":"2006","unstructured":"Hwang JS, Tu ST, Yang TS, Chen JF, Wang CJ, Tsai KS (2006) Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis. Osteoporos Int 17(3):373\u2013378","journal-title":"Osteoporos Int"},{"issue":"6","key":"871_CR25","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","volume":"20","author":"P. Chen","year":"2005","unstructured":"Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB (2005) Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res 20(6):962\u2013970","journal-title":"J Bone Miner Res"},{"issue":"7","key":"871_CR26","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2003-1703","volume":"90","author":"H. Dobnig","year":"2005","unstructured":"Dobnig H, Sipos A, Jiang Y, Fahrleitner-Pammer A, Ste-Marie LG, Gallagher JC, Pavo I, Wang J, Eriksen EF (2005) Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab 90(7):3970\u20133977","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"871_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1185\/030079905X75096","volume":"22","author":"R. Eastell","year":"2006","unstructured":"Eastell R, Krege JH, Chen P, Glass EV, Reginster JY (2006) Development of an algorithm for using PINP to monitor treatment of patients with teriparatide. Curr Med Res Opin 22(1):61\u201366","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"871_CR28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0749-0690(02)00074-5","volume":"19","author":"M.R. Rubin","year":"2003","unstructured":"Rubin MR, Bilezikian JP (2003) The anabolic effects of parathyroid hormone therapy. Clin Geriatr Med 19(2):415\u2013432","journal-title":"Clin Geriatr Med"},{"issue":"9","key":"871_CR29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E. Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357(9): 905\u2013916","journal-title":"N Engl J Med"},{"issue":"3","key":"871_CR30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1359\/jbmr.2003.18.3.539","volume":"18","author":"J.R. Zanchetta","year":"2003","unstructured":"Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL (2003) Effects of teriparatide [recombinant human parathyroid hormone (1\u201334)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18(3):539\u2013543","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-008-0871-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-008-0871-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-008-0871-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:14:23Z","timestamp":1559110463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-008-0871-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1007\/s00774-008-0871-3","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}